We apologize your item could not be found. Not all items are listed on our website. Please contact your account manager for details regarding your searched item.
Material number (eg: xxxxxxxxxxx) no space or hyphen needed.
No Results Found
A West-Sponsored presentation on Monday, November 10, 2014.
Looking to optimize your delivery system to help reduce time to market, manage risk, lower costs and improve patient outcomes? Then join West’s Graham Reynolds, Vice President of Marketing and Innovation, who along with Sherry Martin-Moe, Ph.D Executive Vice President at Enterprise Catalyst Groupand Yen-Heui Lin, Ph.D. Head of Drug Product Sciences, Global CMC Biologics at Teva Pharmaceuticals, will present “Start with the End in Mind.” The presentation will cover:
When: Monday, November 10 8:30 a.m. – 10:30 a.m.
Where: Shire Pharmaceuticals, Chesterbrook Conference Center, 1400 Liberty Ridge Drive Suite 106 Wayne, Pennsylvania 19087
Register now: http://www.cvent.com/d/p4qtmp
We’ll see you there!
Since 1973 West and Daikyo have embarked on a journey of partnership that has been essential to understanding customer challenges and providing solutions. Celebrating 100-years of West this year, it also marks 50-years of partnership with Daikyo. We recently held an engaging team member event with our Daikyo team as part of our ongoing 100th speaker series. It highlighted the importance of this partnership and the continuous strength between the two companies’ symbiotic relationship and mutual goals to bring great value to the offerings and solutions for the customer and ultimately, the patients we jointly serve.
The development of a drug product is an arduous and intricate process. Besides ensuring the sterility and effectiveness of the final product, it should also be as free of particles as possible. In protein-based pharmaceuticals, aggregates may form over time and are mostly detrimental to product quality, as they can affect the efficacy, potency, clinical safety, and immunogenicity of the product.<sup>1-3</sup> Protein aggregates are considered a type of particulate matter (PM), and it is important to minimize their occurrence, as well as to quantify the PM for ensuring the quality and safety of the drug products.
West is pleased to congratulate the recipients of the 2017 H.O. West Foundation academic scholarships! This year the H.O. West scholarship program awarded nine scholarships to deserving high school seniors.
Lyophilization (freeze drying) is the process of dehydrating a material at low temperature and reduced pressure. It is used to extend the shelf life of many biologic drug products (> 400 FDA-approved); because absent water, the rates of degradative processes are reduced substantially. Essential to successful lyophilization, and subsequent rehydration, are use of proper containment and reconstitution systems. <br />
This year not only marks the 10<sup>th</sup> anniversary of our <strong>West without Borders</strong> tradition, but has added a new dimension to the principle of giving. All four West locations in Germany set out to demonstrate their social commitment while hosting a variety of activities in support of a local not-for-profit organization. Thanks to the great efforts of all involved, we were able to generate the record sum of <strong>€20,426.27.</strong>
English
Chinese
